August 26, 2019

In This Issue
MMA Annual Session in Bar Harbor September 6-8
MaineHealth & Anthem to Form Joint Insurance Venture
Celebrate 65 Years of MMA Executive Leadership on Oct. 26. Tickets Available Now
CDC: Many Adults Skip Diabetes Meds Due to Cost
Home Health Changes in CMS Rules: Implications for Primary Diagnosis
This Week's Public Health Updates from the AMA
USPSTF Updates Recommendations for Breast, Ovarian Cancer Gene Screening
CDC Videos on Discussing Vaccines With Parents, Patients
AMA Urges CMS to Reduce Administrative Burden on Physicians
MMA Legislative Calls Finished for the Session
Legislature Returns to Augusta for a Day August 26th
Upcoming Specialty Society Meetings
MICIS Individual Academic Detailing Sessions on Opioid Topics
2019 Clinical & Legal Opioid Update: September 10th at the Augusta Civic Center
2019 Clinical & Legal Opioid Update: MICIS Fall Presentations
VA Maine Healthcare System to Host Community Mental Health Summit on MAT September 11th
Quality Counts: Rapid Induction Starting in the ED (RISE) Training, ECHO Program
Obesity Medicine: There is no 'one size fits all' - Monthly Lecture Series Beginning September 18th
Maine Concussion Management Initiative (MCMI) Training Program - October 9
MMA partners with the Maine Suicide Prevention Program to offer training for clinicians.
Outpatient Internal Medicine Physician Bangor, Maine
BC/BE Family Medicine or Internal Medicine Physician
Northern Light Sebasticook Valley Hospital seeks a BC/BE General Surgeon
Family Medicine Opportunity in Beautiful Western Maine
Physician Director of Primary Care
Family Medicine Specialist or an Internist
Opportunities at the VA for Volunteer Physicians
Volunteer Opportunity with Partners for World Health

Search Back Issues





Follow Us:
USPSTF Updates Recommendations for Breast, Ovarian Cancer Gene Screening

 [from AMA Morning Rounds]

Reuters (8/20, Boggs) reports, “Mutations in the BRCA1 and BRCA2 genes are associated with increased risks for breast, ovarian, and other cancers, but only certain women stand to benefit from genetic testing, according to updated recommendations from the U.S. Preventive Services Task Force (USPSTF).” The task force “recommends genetic testing if a woman’s history suggests a potential for inherited cancer risk, but even then, only if the test results will help her make decisions about further evaluation and treatment.”

The AP (8/20, Neergaard) reports on Tuesday, USPSTF expanded recommendations for who should get screened for BRCA mutations. Previously, the task force recommended screening for “women who have relatives with BRCA-related cancers and refer those who might benefit from gene testing to a genetic counselor to help them decide.” The new recommendations, published in JAMA, now suggest primary care physicians should assess risk for women “previously...treated for breast or other BRCA-related cancers,” and whose “ancestry is prone to BRCA mutations, such as Ashkenazi Jewish women.”

MedPage Today (8/20, Ingram) reports the task force members “recommend a three-step process: a brief risk assessment with a validated tool, referral to genetic counseling if positive, and then BRCA1/2 mutation testing if indicated.” Meanwhile, the group “did not recommend multigene panel testing, omitting other genes linked to increased cancer risk, and instead focused on BRCA1/2 mutations specifically, citing the available evidence on and prevalence of these mutations, and their clinical actionability.”


< Previous Article | Next Article >

[ return to top ]

To ensure delivery of Maine Medicine Weekly Update,
please add 'info@mainemed.com' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details: http://www.commpartners.com/website/white-listing.htm

Unsubscribe here

For more information or to contact us directly, please visit www.mainemed.com | ©